Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 41: 424-429, 1995;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pan, J. P.
Right arrow Articles by Chang, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pan, J. P.
Right arrow Articles by Chang, M. S.

Clinical Chemistry, Vol 41, 424-429, Copyright © 1995 by American Association for Clinical Chemistry

Restriction fragment length polymorphisms of apolipoprotein B gene in Chinese population with coronary heart disease

JP Pan, AN Chiang, JJ Tai, SP Wang and MS Chang
Department of Medicine, Veterans General Hospital-Taipei, National Yang- Ming University, School of Medicine, Taiwan, Republic of China.

Three restriction fragment length polymorphisms (RFLPs), EcoRI (R), Xbal (X), and Mspl (M) of the apolipoprotein (apo)B gene, were studied to determine their distribution frequencies and influence on the lipid profiles in 148 Chinese patients with documented coronary heart disease (CHD) and in 153 healthy subjects. The plasma concentrations of cholesterol and apoB showed no difference between the CHD patients and controls. However, CHD patients had significantly higher concentrations of low-density lipoprotein cholesterol and triglyceride and lower concentrations of high-density lipoprotein cholesterol than the controls. The frequencies of these three apoB RFLPs did not differ between the CHD patients and controls. Compared with South Asians and Caucasians, the Chinese in Taiwan showed a much lower frequency of R-, X+, and M- alleles. There was no evidence of an association between lipid profiles and RFLPs in either CHD patients or controls. The weak association of EcoRI, Xbal, and Mspl polymorphisms of the apoB gene with CHD indicates that the three RFLPs cannot be used as a predictor for the risk of CHD in the Chinese population.


The following articles in journals at HighWire Press have cited this article:


Home page
 J. Med. Genet.Home page
A. Horvath, A. Savov, S. Kirov, E. Karshelova, I. Paskaleva, A. Goudev, and V. Ganev
High frequency of the ApoB-100 R3500Q mutation in Bulgarian hypercholesterolaemic subjects
J. Med. Genet., August 1, 2001; 38(8): 536 - 540.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the American Association for Clinical Chemistry.